← Open Payments lookup

KHALID ARSHAD: Open Payments

NPI 1306259817 · KANKAKEE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,610 in 78 payments from 15 companies in 2025. Trend: 2023 $1,775 · 2024 $1,996 · 2025 $1,610

Food & beverage: $1,610
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.19$427
Neurocrine BioSciences, Inc.14$306
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$151
Alkermes, Inc.7$133
Supernus Pharmaceuticals, Inc.6$126
Tris Pharma Inc6$112
Axsome Therapeutics, Inc.4$105
Janssen Pharmaceuticals, Inc3$55
Luye Pharma (USA) Ltd.2$46
Takeda Pharmaceuticals U.S.A., Inc.2$37

Products named: INGREZZA, REXULTI, ABILIFY ASIMTUFII, CAPLYTA, ARISTADA, Qelbree, Dyanavel XR, Auvelity.

Industry payments across IL — which companies pay providers there.